Pfizer´s (PFE) c.$12bn Zoetis, a Real Spinoff?
0
NEW YORK and LONDON, January 31, 2013 /PRNewswire/ --
"This is an IPO, not a Spinoff... Well not yet!" according to Ryan Mendy, COO of TSR [http://www.spinoffreport.com/contact-us ], the UK based, leading global Spinoff and special situations research firm.
(Photo: http://photos.prnewswire.com/prnh/20130115/588743-b )
TSR´s specialist analyst team have been looking at Pfizer´s (PFE) various break-up potentials closely since 2010. Zoetis (ZTS), PFE´s Animal Health business, is one of 120+ break-ups onTSR´s 2013 calendar, [http://www.spinoffreport.com/research-services/us-spinoffs ] but they believe the best is to come for investors.
"Zoetis is due to be priced today, valued at c.$12bn", comments Mendy [http://www.spinoffreport.com/contact-us ]. "Ourresearch [http://www.spinoffreport.com/contact-us ] sees a better investment angle on PFE if you want ZTS stock? Large investors are apparently oversubscribed to the IPO. There´s still over two thirds [80%] of the company being held back by PFE management. Will they be distributed tax-free? Much better returns are generated fromSpinoffs [http://www.spinoffreport.com/research-services/us-spinoffs ] than IPOs".
And the TSR team have a real edge, they returned +23% in FY2012 to funds using their research and they have a market leading history of both advising and delivering institutional clients solid benchmark outperforming returns from their fundamental analysis, weekly idea generation and recommendations on what future Spinoffs [http://www.spinoffreport.com/contact-us ] and Distressed Equity Situations [http://www.distressedreport.com ] will perform best(?). You can click here to see TSR´s 5 year track record vs. major benchmarks. [http://www.spinoffreport.com/research-model-portfolio ]
PFE, valued at $197bn, are merely selling (raising money) for 20% of ZTS and holding back the rest to see how it performs, thus with no current tax-free distribution of the other 80% of stock back to current PFE shareholders, this is a pure IPO, not a Spinoff [http://www.spinoffreport.com/research-services/us-spinoffs ].
It appears Compuware (CPWR) [http://www.spinoffreport.com/contact-us ] is aiming to carry out a similar process now, just like Sunoco (SUN) [http://www.spinoffreport.com/contact-us ] did with its coke-making business SunCoke Energy (SXC) [http://www.spinoffreport.com/contact-us ] and Dean Foods (DF) [http://www.spinoffreport.com/contact-us ] is planning with its consumer segment, WhiteWave (WWAV). [http://www.spinoffreport.com/contact-us ]
How to get more?
Click here to enquire [http://www.spinoffreport.com/contact-us ] regarding TSR´s [http://www.spinoffreport.com/contact-us ] research of this and other Spinoff´s [http://www.spinoffreport.com/research-services/european-report ] in the US, those in Europe and all other international markets, as well as their upcoming deep value coverage calendar.
Investment sectors covered byThe Spinoff Report(R) [http://www.spinoffreport.com ] &The Distressed Report(TM) [http://www.distressedreport.com ]:
Activism, Bankruptcy, Carve Outs, Deep Value, Catalysts, Demutualizations, Directors Dealings, Distressed Securities, Liquidations, Merger Securities, Mergers & Acquisitions, Post-Re-Orgs, Privatizations, Recapitalizations, Recovery Situations, Equity Restructurings, Reverse Mergers, Reverse Morris Trusts, Rights Offerings, Special Dividends, Spinoffs, Split-offs, Tender Offers and Turnarounds.
Contact
Ryan Mendy, COO [http://www.spinoffreport.com/contact-us ]
The Spinoff Report(R) (TSR)
+1-212-714-7046
http://www.spinoffreport.com
research@spinoffreport.com
Photo:
http://photos.prnewswire.com/prnh/20130115/588743-b
